In the early years of its creation: in 1669, it celebrated the creation of the chemist's chemistry in beijing, marking the creation of its brand. In 1702, rao feng ming opened a pharmacies shop outside the front fence in beijing, and began to supply medicine for the palace, after eight generations of emperors, in 188, laying down its authority in the chinese pharmaceutical industry. Public-private partnership period: in 1954, a public-private partnership was launched in the queen's hall, leading to socialism, which served as a model for the development of the chinese pharmaceutical industry. During this period, a chinese pharmaceutical tablet production plant was set up, creating the first river of chinese medicine-based and pharmaceutical-type reforms. Following the reform and opening up: in 1992, china's china's companion hall group inc. Was formally established. In 1997, after being listed on the shanghai stock exchange, beijing's syndicats ltd. And hong kong's pharmacy development company ltd. Were established to actively expand domestic and foreign markets. Brand culture: for generations, my colleagues have adhered to the ancient teachings of “artillery, albeit unmanageable, and tasteless, and materialistic”, which set up a sense of self-discipline that “required and understood”, ensuring the quality of medicines. Entrepreneurship: the same-student inde, born to the world. It treats the practice of medicine as a noble cause for the survival of the world and for the service of society. It treats all customers equally and insists that children should not be wronged. The company has 36 production bases, 110 modern production lines, six major categories, more than 20 formulations, more than 2600 medicines and health-care foods, covering a wide range of areas such as cardiovascular vessels, gynaecology, thermal, respiratory system, and the god of the good god, including a wide range of chinese medical medicines, such as angiya niumaru, niu niu nieng and baeng xinhua. Wide market coverage: as of the end of 2023, a number of retail outlets under the auspices of a major subsidiary of the same office ran out for the first time, reaching 1001, with the domestic market spread to large cities. At the same time, international markets have been actively developed, for example, through home medicine, which has opened doors or marketing networks in various countries and regions around the world. Excellent performance: throughout 2023, the business income of the same office was 17,861 million yuan, an increase of 16. 19 per cent over the same year, and the net profits attributed to shareholders in listed companies was 1,669 million yuan, an increase of 16,92 per cent over the same year, showing a positive development. The brand honour was recognized by the ministry of commerce of the people's republic of china in 2006 as the first “old chinese characters” and “medical culture in the same room” were selected for the first list of representative national intangible cultural heritage. “china mark gold award - trademark application award” “madrid special award for international registration of trade marks” “first beijing people's government quality management award” “new china 70th anniversary pharmaceutical industry company award” on 3 april 2023, the chinese medicine community brand ranked 2022 hu yun as the fourth health brand value. Brand development strategy: the development strategy of “developing a life-health industry centred on modern chinese medicine and becoming an internationally recognized modern chinese medicine group” with a “long, strong and large” approach, with innovation leading, technological growth and three blocks of modern pharmaceutical industry, retail commerce and health services, and an enterprise structure of six secondary groups, three chambers and two reserve units。